InnoCan Pharma Corp (INNO)

CSE
0.52
+0.02(+4.00%)
  • Volume:
    16,470
  • Bid/Ask:
    0.52/0.54
  • Day's Range:
    0.52 - 0.54
  • Type:Equity
  • Market:Canada
  • ISIN:CA45783P1027
  • CUSIP:45783P102

INNO Overview

Prev. Close
0.5
Day's Range
0.52-0.54
Revenue
-
Open
0.54
52 wk Range
0.4-1.65
EPS
-0.02
Volume
16,470
Market Cap
124.26M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
46,624
P/E Ratio
-
Beta
-
1-Year Change
2.04%
Shares Outstanding
248,518,197
Next Earnings Date
-
What is your sentiment on InnoCan Pharma?
or
Vote to see community's results!

InnoCan Pharma Corp Company Profile

InnoCan Pharma Corp Company Profile

Employees
0
Market
Canada

InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. The company engages in the research and development of Covid-19 treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. The company was incorporated in 2018 and is headquartered in Calgary, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsSellSellSellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral